JP5468183B2 - ＩｇＡ産生促進作用を有する新規乳酸菌及びその用途 - Google Patents

ＩｇＡ産生促進作用を有する新規乳酸菌及びその用途 Download PDF

Info

Publication number
JP5468183B2
JP5468183B2 JP2013534101A JP2013534101A JP5468183B2 JP 5468183 B2 JP5468183 B2 JP 5468183B2 JP 2013534101 A JP2013534101 A JP 2013534101A JP 2013534101 A JP2013534101 A JP 2013534101A JP 5468183 B2 JP5468183 B2 JP 5468183B2
Authority
JP
Japan
Prior art keywords
lactic acid
strain
acid bacteria
lactobacillus
bps402
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2013534101A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2013099883A1 (ja
Inventor
大介 松浦
孝志 浅間
弘典 元木
智基 立藤
健 橋本
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yamada Bee Co Inc
Original Assignee
Yamada Bee Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamada Bee Co Inc filed Critical Yamada Bee Co Inc
Priority to JP2013534101A priority Critical patent/JP5468183B2/ja
Application granted granted Critical
Publication of JP5468183B2 publication Critical patent/JP5468183B2/ja
Publication of JPWO2013099883A1 publication Critical patent/JPWO2013099883A1/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0212—Face masks
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9728—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Nutrition Science (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Botany (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP2013534101A 2011-12-28 2012-12-25 ＩｇＡ産生促進作用を有する新規乳酸菌及びその用途 Active JP5468183B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2013534101A JP5468183B2 (ja) 2011-12-28 2012-12-25 ＩｇＡ産生促進作用を有する新規乳酸菌及びその用途

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2011289314 2011-12-28
JP2011289314 2011-12-28
JP2013534101A JP5468183B2 (ja) 2011-12-28 2012-12-25 ＩｇＡ産生促進作用を有する新規乳酸菌及びその用途
PCT/JP2012/083523 WO2013099883A1 (ja) 2011-12-28 2012-12-25 IgA産生促進作用を有する新規乳酸菌及びその用途

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013247797A Division JP6420535B2 (ja) 2011-12-28 2013-11-29 ＩｇＡ産生促進作用を有する新規乳酸菌及びその用途

Publications (2)

Publication Number Publication Date
JP5468183B2 true JP5468183B2 (ja) 2014-04-09
JPWO2013099883A1 JPWO2013099883A1 (ja) 2015-05-07

Family

ID=48697368

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2013534101A Active JP5468183B2 (ja) 2011-12-28 2012-12-25 ＩｇＡ産生促進作用を有する新規乳酸菌及びその用途
JP2013247797A Active JP6420535B2 (ja) 2011-12-28 2013-11-29 ＩｇＡ産生促進作用を有する新規乳酸菌及びその用途
JP2017145866A Active JP6685974B2 (ja) 2011-12-28 2017-07-27 ＩｇＡ産生促進作用を有する新規乳酸菌及びその用途

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2013247797A Active JP6420535B2 (ja) 2011-12-28 2013-11-29 ＩｇＡ産生促進作用を有する新規乳酸菌及びその用途
JP2017145866A Active JP6685974B2 (ja) 2011-12-28 2017-07-27 ＩｇＡ産生促進作用を有する新規乳酸菌及びその用途

Country Status (3)

Country Link
US (2) US9856451B2 (https=)
JP (3) JP5468183B2 (https=)
WO (1) WO2013099883A1 (https=)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020090321A1 (ja) 2018-10-30 2020-05-07 株式会社村田製作所 熱ショックタンパク質遺伝子発現調整剤、医薬品、化粧品、及び熱ショックタンパク質遺伝子発現調整剤の製造方法
WO2021059986A1 (ja) 2019-09-25 2021-04-01 株式会社村田製作所 コラーゲン産生亢進剤、医薬品、化粧品、及びコラーゲン産生亢進剤の製造方法

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013099883A1 (ja) 2011-12-28 2013-07-04 株式会社山田養蜂場本社 IgA産生促進作用を有する新規乳酸菌及びその用途
JP2015030688A (ja) * 2013-08-01 2015-02-16 興人ライフサイエンス株式会社 栄養組成物
JP6486612B2 (ja) * 2014-05-27 2019-03-20 株式会社山田養蜂場本社 抗アレルギー作用を有する乳酸菌及びその用途
JP6457963B2 (ja) * 2016-02-25 2019-01-23 日清ファルマ株式会社 大腸デリバリーカプセル製剤
CN110249055B (zh) * 2016-12-28 2023-01-03 株式会社山田养蜂场本社 发酵物及其制造方法
CN110446786A (zh) * 2016-12-28 2019-11-12 株式会社山田养蜂场本社 蜂蜜发酵物及其制造方法
JP6994214B2 (ja) * 2017-05-01 2022-02-21 日本コルマー株式会社 皮膚改善用食品組成物
PL233794B1 (pl) * 2017-11-06 2019-11-29 Biowet Pulawy Spolka Z Ograniczona Odpowiedzialnoscia Szczepy bakterii z rodzajow Lactobacillus i Fructobacillus wyizolowane z przewodu pokarmowego pszczol miodnych do zastosowania w zwalczaniu i zapobieganiu chorob pszczol oraz preparaty probiotyczne na bazie takich szczepow bakterii
IT201800007229A1 (it) * 2018-07-16 2020-01-16 Processo microbiologico per la produzione di pane d’api
TWI689585B (zh) * 2018-12-10 2020-04-01 日商奧碧慧央集團股份有限公司 新穎乳酸菌株及包含新穎乳酸菌株之免疫賦活劑
JP7488573B2 (ja) * 2021-01-14 2024-05-22 株式会社山田養蜂場本社 マクロファージ活性剤
JP2022132724A (ja) * 2021-03-01 2022-09-13 国立研究開発法人農業・食品産業技術総合研究機構 免疫グロブリンａ分泌促進剤
JP7717383B2 (ja) * 2022-03-03 2025-08-04 株式会社アルソア慧央グループ 腸管免疫賦活剤、ＩｇＡ産生促進剤及び遺伝子発現促進剤
JP7663240B2 (ja) * 2022-03-03 2025-04-16 株式会社アルソア慧央グループ 腸管免疫賦活剤及びＩｇＡ産生促進剤
WO2023229282A1 (ko) * 2022-05-25 2023-11-30 전남대학교산학협력단 락토바실러스 쿤케이 nchbl-003 균주 또는 이의 배양액을 포함하는 대사성 질환 예방, 치료 또는 개선용 조성물
KR20240164663A (ko) * 2023-05-11 2024-11-20 전남대학교산학협력단 락토바실러스 쿤케이 nchbl-003 균주 또는 이의 사균체를 유효성분으로 포함하는 호흡기 질환 또는 염증성 질환 치료, 예방 또는 개선용 조성물

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004502633A (ja) * 1999-01-15 2004-01-29 エンタープライズ・アイルランド（トレイディング・アズ・バイオリサーチ・アイルランド） ラクトバチルス・サリバリウス（Ｌａｃｔｏｂａｃｉｌｌｕｓｓａｌｉｖａｒｉｕｓ）の使用
WO2004076615A2 (en) * 2003-02-27 2004-09-10 Bioneer A/S Immunomodulating probiotic compounds
JP2007070249A (ja) * 2005-09-05 2007-03-22 Shinshu Univ 免疫機能調節剤、抗アレルギー剤、免疫調節用組成物及び抗アレルギー用組成物並びにこれらが含まれた食品
JP2009509981A (ja) * 2005-09-28 2009-03-12 ノルディスク リバランス アクティーゼルスカブ 治療エフェクターとしてプロバイオティック細菌と発酵穀物を用いるｉｂｄ及びｉｂｓの治療
JP2009511471A (ja) * 2005-10-06 2009-03-19 プロビ エービー 自己免疫疾患治療のための乳酸菌の使用
JP2010525809A (ja) * 2007-05-03 2010-07-29 オロフソン、トビアス 新鮮な蜂蜜又はミツバチの蜂蜜産生管から単離された新規細菌

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0564555A (ja) 1991-09-04 1993-03-19 Kojundo Chem Lab Co Ltd 蜜蜂生産物とその採取方法
DE4232732C1 (de) 1992-09-30 1994-02-03 Gsf Forschungszentrum Umwelt Standardisiertes Gelee Royale, Verfahren zu seiner Gewinnung und seine Verwendung
JPH08143462A (ja) 1994-11-18 1996-06-04 San Crest:Kk 免疫賦活剤及び抗腫瘍剤
IT1276783B1 (it) 1995-06-23 1997-11-03 Bracco Spa Formulazioni farmaceutiche e dietetiche per la profilassi e la cura di affezioni gastrointestinali
JP3944076B2 (ja) 2000-08-25 2007-07-11 わかもと製薬株式会社 乳酸菌含有プロバイオティクス製品
JP2002241289A (ja) 2001-02-16 2002-08-28 Ichimaru Pharcos Co Ltd 肥厚化角質層柔軟化剤
US8852916B2 (en) * 2010-01-22 2014-10-07 The Invention Science Fund I, Llc Compositions and methods for therapeutic delivery with microorganisms
JP2007269737A (ja) 2006-03-31 2007-10-18 Morinaga Milk Ind Co Ltd インターロイキン産生調節剤、該インターロイキン産生調節剤を含む医薬組成物及び飲食品、並びにその製造方法
JP5266596B2 (ja) 2006-12-28 2013-08-21 グリコ乳業株式会社 免疫賦活作用を有する乳酸菌，免疫賦活作用を有する製品及びその製造方法
JP5144085B2 (ja) 2007-02-20 2013-02-13 国立大学法人 東京大学 ＩｇＡ抗体産生向上作用をもつ乳酸菌を含有する腸管免疫力増強剤
US8728461B2 (en) 2008-07-04 2014-05-20 Nippon Meat Packers, Inc. Lactic acid bacterium having high immunoglobulin-A-inducing ability
JP2010057395A (ja) 2008-09-02 2010-03-18 Kizakura Co Ltd 腸管免疫調節作用を有する乳酸菌
JP5585769B2 (ja) 2009-05-15 2014-09-10 ダイソー株式会社 腸管免疫賦活能を有する乳酸菌に対する効果促進剤
WO2013099883A1 (ja) 2011-12-28 2013-07-04 株式会社山田養蜂場本社 IgA産生促進作用を有する新規乳酸菌及びその用途

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004502633A (ja) * 1999-01-15 2004-01-29 エンタープライズ・アイルランド（トレイディング・アズ・バイオリサーチ・アイルランド） ラクトバチルス・サリバリウス（Ｌａｃｔｏｂａｃｉｌｌｕｓｓａｌｉｖａｒｉｕｓ）の使用
WO2004076615A2 (en) * 2003-02-27 2004-09-10 Bioneer A/S Immunomodulating probiotic compounds
JP2007070249A (ja) * 2005-09-05 2007-03-22 Shinshu Univ 免疫機能調節剤、抗アレルギー剤、免疫調節用組成物及び抗アレルギー用組成物並びにこれらが含まれた食品
JP2009509981A (ja) * 2005-09-28 2009-03-12 ノルディスク リバランス アクティーゼルスカブ 治療エフェクターとしてプロバイオティック細菌と発酵穀物を用いるｉｂｄ及びｉｂｓの治療
JP2009511471A (ja) * 2005-10-06 2009-03-19 プロビ エービー 自己免疫疾患治療のための乳酸菌の使用
JP2010525809A (ja) * 2007-05-03 2010-07-29 オロフソン、トビアス 新鮮な蜂蜜又はミツバチの蜂蜜産生管から単離された新規細菌

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
JPN6013003274; ＭＡＬＩＮ　Ｍ．　ｅｔ　ａｌ．，: 'Ｐｒｏｍｏｔｉｏｎ　ｏｆ　ＩｇＡ　Ｉｍｍｕｎｅ　Ｒｅｓｐｏｎｓｅ　ｉｎ　Ｐａｔｉｅｎｔｓ　ｗｉｔｈ　Ｃｒｏｈｎ'ｓ　Ｄｉｓｅａｓｅ　ｂｙ　Ｏｒａｌ　Ｂａｃｔｅｒｉｏｔｈｅｒａｐｙ　ｗｉｔｈ　Ｌａｃｔｏ' Ａｎｎａｌｓ　ｏｆ　Ｎｕｔｒｉｔｉｏｎ　ａｎｄ　Ｍｅｔａｂｏｌｉｓｍ，　１９９６，　Ｖｏｌ．４０，　ｐｐ．１３７-１４５ *
JPN6013047982; 'Ｊｏｕｒｎａｌ　ｏｆ　Ｂａｃｔｅｒｉｏｌｏｇｙ' ２００９，　Ｖｏｌ．１９１，　Ｎｏ．２４，　ｐｐ．７６３０-７６３１ *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020090321A1 (ja) 2018-10-30 2020-05-07 株式会社村田製作所 熱ショックタンパク質遺伝子発現調整剤、医薬品、化粧品、及び熱ショックタンパク質遺伝子発現調整剤の製造方法
WO2021059986A1 (ja) 2019-09-25 2021-04-01 株式会社村田製作所 コラーゲン産生亢進剤、医薬品、化粧品、及びコラーゲン産生亢進剤の製造方法

Also Published As

Publication number Publication date
WO2013099883A1 (ja) 2013-07-04
US20180112176A1 (en) 2018-04-26
JP6685974B2 (ja) 2020-04-22
JPWO2013099883A1 (ja) 2015-05-07
JP6420535B2 (ja) 2018-11-07
US20140363880A1 (en) 2014-12-11
US9856451B2 (en) 2018-01-02
US10570366B2 (en) 2020-02-25
JP2018008980A (ja) 2018-01-18
JP2014073130A (ja) 2014-04-24

Similar Documents

Publication Publication Date Title
JP5468183B2 (ja) ＩｇＡ産生促進作用を有する新規乳酸菌及びその用途
EP2455450B1 (en) Novel lactobacillus plantarum and composition containing same
EP2360237B1 (en) Novel lactobacillus plantarum and composition containing the same
EP3735456B1 (en) A novel lactic acid bacteria and its applications
JP7179343B2 (ja) 新規な乳酸菌株およびそれを含む免疫賦活剤
KR102543494B1 (ko) 신규 프로바이오틱스 및 이의 용도
WO2024195814A1 (ja) 免疫賦活用組成物
WO2019045037A1 (ja) ヒアルロン酸産生促進用組成物
KR102368628B1 (ko) Iv형 알레르기용 조성물
JP6486612B2 (ja) 抗アレルギー作用を有する乳酸菌及びその用途
JP2021527414A (ja) ロイコノストック属菌株を含む腸機能改善用組成物
JP7362081B2 (ja) 新規な乳酸菌株及びその用途
WO2006087913A1 (ja) 免疫賦活用組成物
JP6557605B2 (ja) 乳酸菌を含む腸管バリア機能亢進剤
WO2025206173A1 (ja) 免疫賦活能を有する細菌を含む組成物
TW202335676A (zh) 腸管免疫賦活劑及IgA產生促進劑
HK1226605A1 (en) Intestinal barrier function enhancer containing lactic acid bacteria
HK1171474B (en) Novel lactobacillus plantarum and composition comprising same
HK1171474A1 (en) Novel lactobacillus plantarum and composition comprising same

Legal Events

Date Code Title Description
TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20140107

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20140128

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

Ref document number: 5468183

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250